28 June - 1 July 2017
Barcelona, Spain

2017 Satellite Symposia

Independent satellite symposia, supported by a variety of companies and organizations, will be open to Congress attendees free of charge. Topics have been chosen to complement the plenary sessions of the Congress.

However, please note that these symposia are organized separately and independently. These sessions are not part of the Congress. Continuing education credit is at the discretion of the symposia organizer.

 

Wednesday, 28 June 2017
13:30 - 14:30
Exclusive Lunch Mini-symposium

Anti-VEGF Monoclonal Antibodies in Oncology: The Case for Biosimilars

Room 117, Level 1
Supported by Amgen Biosimilars
View Agenda

Wednesday, 28 June 2017
19:00 - 20:30
Concurrent Evening Non-profit Symposia

European Workshop: Nutritional Support in GI Cancer Patients

Room 115, Level 1
Presented by ESDO – European Society of Digestive Oncology
View Agenda

Innovations and Care in the Next 12 Months: 14th ESO Colorectal Cancer Observatory

Room 116, Level 1
Presented by ESO - European School of Oncology
View Agenda

Congress Welcome Reception begins in Room 117 immediately following the evening's symposia

Thursday, 29 June 2017
13:30 - 15:00
Concurrent Luncheon Symposia

Global Insights on Translating Scientific Evidence into Clinical Practice

Rooms 111-112, Level 1
Supported by Lilly Oncology
View Agenda

Redefining Later Line Therapy In mCRC

Rooms 113-115, Level 1
Supported by Servier
View Agenda

Optimizing the Continuum of Care for Patients with Pancreatic Cancer: A Case Study-Based Debate

Rooms 116-117, Level 1
Supported by Celgene International Sàrl
View Agenda

Friday, 30 June 2017
13:20 – 14:50
Concurrent luncheon symposia

Navigating Treatment Decisions in Metastatic Pancreatic Cancer

Rooms 111-112, Level 1
Presented by Prime Oncology
View Agenda

Rethinking Second-Line Therapy in Metastatic Colorectal Cancer: Breaking the Mold

Rooms 113-115, Level 1
Supported by Sanofi Genzyme
View Agenda

SIR-Spheres® Y-90 Resin Microspheres: Changing Practice in mCRC and HCC?

Rooms 116-117, Level 1
Supported by Sirtex Medical Europe GmbH
View Agenda

Saturday, 1 July 2017
13:15 - 14:45
Concurrent luncheon symposia

Optimizing Clinical Outcomes in Gastrointestinal Cancers through Multikinase Inhibition

Rooms 113-115, Level 1
Supported by Bayer HealthCare
View Agenda

Optimising Patient Outcomes in RAS WT mCRC

Rooms 116-117, Level 1
Supported by Amgen Oncology
View Agenda